How long will Wegovy take to start working — and what counts as progress?

What actually happens in your body in the first few weeks

Wegovy (semaglutide) is a GLP-1 receptor agonist. It mimics a gut hormone that signals fullness to the brain, slows how quickly food leaves your stomach, and reduces appetite between meals. None of that switches on instantly, your body adjusts to the medicine gradually, which is precisely why treatment starts at 0.25 mg rather than the maintenance dose.

In those early weeks, the most honest thing to expect is a subtle shift in hunger rather than a dramatic drop on the scales. Some people notice they feel full after less food at a sitting; others find they stop thinking about snacks as often. That quietening of appetite is the medicine beginning to do its job. Weight on the scales may barely move at this point, and that is normal. The 0.25 mg starting dose is there to help your system adjust, not to deliver peak effect.

A practical check worth doing: once a week, at the same time of day and under the same conditions (first thing in the morning, after using the loo, before eating), weigh yourself and note it down. A single number tells you little; a four-week trend tells you a great deal more. If you are curious about how fast Wegovy starts working in those opening weeks, it helps to understand what early signs are worth paying attention to, and you can read more about the early signs that Wegovy is taking effect if you want a closer look at what to watch for.

The titration phase: why months two to four are when results accelerate

The standard semaglutide pathway moves through 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg, with roughly four weeks at each level before your prescriber considers the next step. By the time you reach the higher doses, the appetite-suppressing effect is substantially stronger, and that is when most people see more noticeable changes on the scales.

This is also when side effects, which are mostly gastrointestinal (nausea, loose stools, reflux), tend to settle. The titration schedule exists partly to reduce those early effects, so skipping ahead is counterproductive. Your prescriber holds the pace, not the calendar.

The weight-loss timeline on Wegovy differs from person to person, body composition, insulin sensitivity, dietary habits, and activity levels all influence how quickly the higher doses translate into visible change. Some people lose noticeable weight at 1.0 mg; others find the real momentum only comes at 1.7 mg or 2.4 mg. Neither pattern means the medicine is or is not working; it means individual variation is real and your prescriber's ongoing review matters. For a detailed look at how long till Wegovy starts working at each stage of the titration, it is worth setting realistic expectations before you reach the higher doses.

What the long-term trial data actually shows

The STEP 1 trial, published in the New England Journal of Medicine, followed adults with obesity over 68 weeks. On the 2.4 mg weekly dose, participants lost an average of around 15% of their body weight alongside a reduced-calorie diet and increased activity. That figure represents sustained, compounding progress across more than a year, not a result that arrived in week three.

For context: 15% of body weight over 68 weeks averages out to well under half a kilogram per week. Some weeks nothing moved; others, more did. The lesson from trial data is that the direction of travel across months matters far more than any individual weigh-in. The NHS semaglutide medicines page also sets realistic expectations about how the medicine works in practice.

NICE recommends reviewing progress at six months on the maintenance dose; if weight loss is less than 5% at that point, continuing treatment is assessed with your prescriber. That review milestone is worth knowing about from the start, it is not a failure threshold, but a structured checkpoint built into good clinical care.

The decision you are actually facing

If you are weighing up whether to start, or wondering whether the medicine is working for you, the timeline question is really a question about patience and process. Wegovy is not a quick fix, and no responsible prescriber would frame it as one. The medicine works progressively, and the people who get the most from it tend to be those who give the titration schedule time to do its work, keep an eye on trend rather than daily fluctuation, and stay in contact with their clinical team when things feel uncertain.

Thinking about what treatment involves before committing is sensible, and it is worth looking at the full Wegovy overview alongside questions about cost, the Wegovy price page breaks down what private treatment typically involves and what to look for in a provider. If you are ready to talk to a prescriber about whether Wegovy suits your situation, our clinical team at nume offers a free consultation reviewed the same day by a GPhC-registered Independent Prescriber. There are no waiting lists and no subscriptions. Start your free consultation and get a clinical view on what to expect for you specifically.